Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tiago Rodrigues has a total of 271 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Natural metabolites from Tabebuia aurea reveal isoform-specific and cooperative modulation of cathepsins B and L

    by Marli de Fátima Correa Emiliano, Mariele Rondon Santos Gonçalves, Leice Milla Ribeiro de Novais, Marcos José Jacinto, Paulo Teixeira de Sousa, Mário Geraldo de Carvalho, Rayssa de Mello Lopes, Maurício Ferreira Marcondes Machado, Ana Laura Ferreira Vicco, Maria Luiza Gonçalves Gallego Rosa, et al.


  • Open Access

    Antiproliferation and Anti-invasion Activity of Binuclear Copper(II) Complex in BRAFi-Resistant Melanoma Cells

    by Manoel Oliveira de Moraes Junior, Larissa AnastácIo da Costa Carvalho, Yasmin Catherine da Paz Mendonça, Renaira Oliveira da Silva, Cleia Justino Nunes, Keli Lima, João Agostinho Machado-Neto, Tiago Rodrigues, Vito Rebecca, Corine Bertolotto, et al.

    Melanoma lethality is driven by high intratumoral heterogeneity, metastatic competence, and phenotypic plasticity, which foster rapid emergence of resistance to targeted therapies such as BRAF inhibitors (BRAFi, e.g. vemurafenib). Copper(II) complexes have emerged as promising anticancer candidates, yet their activity against BRAFi-resistant melanoma remains poorly defined. Here, we show that the binuclear copper(II) complex [Cu2(apyhist)2dpam](ClO4)4 (herein referred to as [Cu(II)L]) displays low-micromolar cytotoxicity and antiproliferative activity in parental and BRAFi-resistant melanoma models. Binuclear [Cu(II)L] suppresses melanoma migration and invasion and reduces tumor burden and dermal invasion in a reconstructed human skin melanoma model with limited toxicity to normal tissue. Mechanistically, [Cu2(apyhist)2dpam](ClO4)4 triggers a ROS-dependent stress response that is attenuated by N-acetylcysteine, leading to DNA damage, mitochondrial depolarization and caspase-independent cell death. Molecular profiling indicates engagement of cell cycle arrest and stress-adaptation programs, with signatures suggesting ferroptotic-associated, necroptotic and autophagy-related signaling, pointing to a redox-driven, diverse mechanism rather than a single dominant death pathway. Different modulation of key markers (PARP1, H2AX, MLKL, GPX4, LC3B-II, and p62) supports that its multitarget activity can bypass adaptive resistance mechanisms. Collectively, these findings support binuclear [Cu(II)L] as a candidate to target invasive and drug-resistant melanoma phenotypes.

  • Open Access

    Imidazo[1,2- a ]pyridines as Privileged Scaffolds: Synthetic Advances, Biological Activities, and Translational Challenges

    by Giorgio Antoniolli, Rebeca Chaguri, Lorraine Alves Grabauskas, Denise Costa Arruda, Tiago Rodrigues

    Imidazo[1,2-a]pyridine derivatives are privileged scaffolds in medicinal chemistry due to their structural versatility, favorable physicochemical properties, and broad pharmacological relevance. Their fused heterocyclic framework enables extensive functionalization while preserving conformational rigidity and optimal heteroatom distribution, making this core highly attractive for drug discovery. This systematic review summarizes recent advances (last 5 years) in the synthesis, structural diversification, and biological evaluation of imidazo[1,2-a]pyridine-based compounds. A comprehensive literature search was performed using the Scopus and Web of Science databases, focusing on studies reporting relevant biological data. The reviewed derivatives display diverse pharmacological activities, including anticancer, antimicrobial, antitubercular, antifungal, antiparasitic, neuroactive, anti-inflammatory, antidiabetic, and ferroptosis-modulating effects. Emphasis is placed on structure–activity relationships, scaffold-hopping strategies, and emerging hybrid designs. Despite promising in vitro potency against multiple therapeutic targets, important limitations remain. Many compounds still lack in vivo validation, pharmacokinetic characterization, and ADME/Tox optimization, restricting their progression toward preclinical development. In addition, structural exploration remains concentrated on conventional substitution patterns, underscoring the need for broader bioisosteric and fragment-based approaches. Overall, this review consolidates recent advances, highlights critical knowledge gaps, and outlines future directions for the rational development of imidazo[1,2-a]pyridine-based therapeutics.

  • Open Access

    MAPK-driven remodeling of mitochondrial dynamics in melanoma: implications for metabolic plasticity and response to targeted therapy

    by L.F.L. Prado-Souza, L.A. Grabauskas, R. Chaguri, C.D. Cardoso, F.Y. Urushima, L.G.R. Mangini, V.S. Ramos, T. Rodrigues


  • Open Access

    Mitochondria-mediated apoptosis induced by acetogenins from Porcelia macrocarpa (Annonaceae) in K562 chronic myeloid leukemia cells

    by Rayssa de M. Lopes, Giorgio Antoniolli, Bárbara A. Frutuoso, Franciny Y. Urushima, Lorraine A. Grabauskas, Dorca Ferreira, Ivanildo A. Brito, Loraine Elizabeth M. Ferreira, Savio R. Soares, Jorge L. Maria Ruiz, et al.

  • Open Access

    Kunitz-type serine protease inhibitor rBmTI-6 as a potential therapeutic lead for lung adenocarcinoma

    by Gilmara B. Lima, Everton Nencioni, Fábio Thimoteo, Rafaela F.A. Pinto, Isabella Pierina, Rayssa de M. Lopes, Tiago Rodrigues, Sergio D. Sasaki

  • AVALIAÇÃO MICROBIOLÓGICA E FÍSICO-QUÍMICA DE PETISCOS CANINOS FORMULADOS COM EXTRATO AQUOSO DE PRÓPOLIS

    by Ana Carolina Pinto da Fonseca, Alessandra Casagrnade Ribeiro, Tiago Rodrigues, Tatiane Faustino de

    Objetivo: Avaliar, de forma preliminar, as características microbiológicas e físico-químicas de petiscos caninos contendo diferentes concentrações de própolis. Métodos: Foram desenvolvidas quatro formulações: controle (0%) e com 0,3%, 0,5% e 1,0% de própolis. Foram realizadas análises microbiológicas de aeróbios mesófilos, Enterobacteriaceae, fungos e leveduras, além de determinações de pH, umidade, cinzas, lipídios, proteínas e carboidratos. Resultados: Não houve crescimento de aeróbios mesófilos e Enterobacteriaceae. A formulação controle não apresentou crescimento em PDA, enquanto as formulações com própolis apresentaram baixas contagens de fungos e leveduras. As amostras apresentaram pH levemente ácido, baixos teores de umidade e valores semelhantes de lipídios. A formulação com 1,0% de própolis apresentou maior teor de proteínas e menor umidade. Conclusão: A incorporação de própolis às formulações de petiscos caninos foi tecnicamente viável, sem alterações negativas relevantes nos parâmetros avaliados. Entretanto, os resultados são preliminares e não permitem definir a concentração mais adequada, sendo necessários estudos complementares de estabilidade (Shelf Life), microbiologia e replicação dos ensaios.

  • Open Access

    Antioxidant Activity of Perphenazine

    by Michal Otreba, Anna Rzepecka-Stojko, Łukasz Marek, Tiago Rodriguez, Jerzy Stojko

    Reactive oxygen species (ROS) play a dual role in the human body; they are essential for normal cellular signaling but, when produced in excess, can disrupt metabolic processes and induce oxidative stress. The body relies on various defense mechanisms to neutralize ROS. Phenothiazine derivatives, due to their core tricyclic structure, are considered potential antioxidants. This study focused on evaluating the antioxidant capacity of perphenazine, a representative phenothiazine derivative, and comparing it to well-known antioxidants, Trolox and ascorbic acid. To achieve this, a series of spectrophotometric assays were performed: ABTS, DPPH, CUPRAC, FRAP, and superoxide anion (O2•−) scavenging. The results indicate that perphenazine shows significant antioxidant properties, particularly through its ability to reduce copper (Cu²⁺) and iron (Fe³⁺) ions and to scavenge ABTS•⁺ radicals. In contrast, its activity against DPPH• and superoxide anions was less pronounced. Relative antioxidant effectiveness, based on IC50 values, followed the order: CUPRAC > FRAP > ABTS > O2•− > DPPH. These findings suggest that perphenazine possesses selective antioxidant potential. Further studies on other phenothiazine derivatives are warranted to comprehensively assess their antioxidative potential.

  • Open Access

    Nitric oxide modulates UDP-evoked cytosolic transients via P2Y6 purinoceptor stimulation

    by Talita Correa, Gioconda E. D. D. Moura, Helena B. Nader, Letícia Silva Ferraz, Ivarne L. S. Tersariol, Tiago Rodrigues, Fábio D. Nascimento

    Glycosaminoglycans (GAGs) and proteoglycans are key components of the extracellular matrix, playing structural and regulatory roles in various biological processes. GAGs are involved in modulating endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) production. CHO-745 cells, deficient in GAGs, produce significantly higher NO levels than wild-type CHO-K1 cells. Since NO is crucial for vascular function, this study investigated how NO overproduction in GAG-deficient cells affects cytosolic Ca2⁺ transients triggered by P2Y6 receptor (P2Y6R) activation with UDP, a vascular tone regulator. Results showed that GAG-deficient CHO-745 cells experience basal oxidative and nitrosative stress. Although integrin expression was similar, the RGD peptide increased NO production in CHO-K1 but not in CHO-745. P2Y6R activation involved phospholipase C and endoplasmic reticulum (ER) Ca2⁺ stores, processes dependent on surface GAGs. Additionally, store-operated Ca2⁺ entry and Na⁺/Ca2⁺ exchanger (NCX) were involved in UDP-induced Ca2⁺ responses, influenced by NO levels. Excess NO also contributed to ER stress and cell death, particularly in the absence of GAGs. Overall, GAG deficiency leads to oxidative stress, disrupted Ca2⁺ homeostasis, ER stress, and apoptosis, underscoring the importance of GAGs in purinergic signaling and vascular physiology.


  • Emerging Roles of Sodium/Calcium Exchangers in Cancer

    by Tiago Rodrigues, Vyctória dos Santos Ramos, Laura Francisca Leite Do Prado-Souza, Ivarne Luis dos Santos Tersariol